Lisbon, Portugal. – ANGANY CEO Dr. Louis-Philippe Vézina and other members of the leadership team of the company attended the European Academy of Allergy and Clinical Immunology’s annual meeting. This was a unique opportunity to meet high-level allergy science key opinion leaders and various pharmaceutical company executives, providing valuable insights to ANGANY’s development of its own suite of products and the dynamics of the allergy pharmaceutical industry in general.
